Sign In
Buy ICCC
$10.05
+0.260 (+2.66%)
At Close: Jun 03, 2026
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
10:46am, Monday, 25'th May 2026
ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health products boosts margins and market share.
ImmuCell Q1 Earnings Call Highlights
11:07am, Friday, 15'th May 2026
ImmuCell NASDAQ: ICCC reported a record first quarter of 2026, with management saying the company's narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever qua
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript
10:40am, Friday, 15'th May 2026
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
04:05pm, Thursday, 14'th May 2026
PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to im
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
04:05pm, Thursday, 07'th May 2026
PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to im
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell
05:01am, Wednesday, 22'nd Apr 2026
Goldman Sachs, NextEra Energy and Shopify lead top stock reports, highlighting strong gains, expanding operations and strategic shifts driving growth.
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
04:05pm, Wednesday, 08'th Apr 2026
PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and marke
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why
02:45am, Thursday, 26'th Mar 2026
ImmuCell Corporation (NASDAQ: ICCC - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $6.11 and traded as high as $6.45.
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
04:05pm, Wednesday, 18'th Mar 2026
PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and market
ImmuCell Q4 Earnings Call Highlights
04:49am, Saturday, 07'th Mar 2026
ImmuCell (NASDAQ: ICCC) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight a year of operational change, improved margins, and a strategic pivot toward expandin
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve
01:46pm, Friday, 06'th Mar 2026
ICCC's 2025 sales rise 4.3% y/y, with the gross margin expanding sharply, helping narrow its annual net loss despite asset write-downs and strategic shifts.
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
03:05pm, Thursday, 05'th Mar 2026
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
04:05pm, Wednesday, 04'th Mar 2026
PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets product
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
08:37am, Wednesday, 18'th Feb 2026
PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products
